VanEck Associates More Than Doubled Its Stake in AST SpaceMobile. Is Now a Smart Time to Buy Shares of the Satellite Manufacturer?

VanEck increased its AST SpaceMobile stake 125% in Q3 2025 to 782,041 shares worth $69.7M (previously $38.4M), implying an ~81% unrealized gain since purchase. AST reported becoming revenue-generating in Q4 2025 with $70.9M driven by U.S. government contracts, launched its sixth BlueBird satellite and plans monthly launches to reach 45–60 satellites by end-2026 with initial commercial DTC activation possible later this year. Analysts polled expect first profit in 2027 and EPS to exceed $1 in 2028, though valuation risk remains (stock ~ $89 implies ~89x prospective $1 EPS).

Analysis

Revenue skew toward government contracts can create an optical inflection without proving retail unit economics; governments buy capacity at different margins and cadence, so early top-line does not validate ARPU, customer acquisition costs, or handset certification timelines. The business hinge is two-fold: (1) ability to reach scale in affordable, carrier-integrated handsets/SIM arrangements and (2) predictable launch cadence without meaningful cost overruns — both govern cash burn more than headline revenue.

A concentrated institutional bid can amplify near-term upside but also sets up sharp reversals at rebalancing windows or after any single failed launch; options skew will likely price in elevated tail risk around each launch, increasing implied funding costs for levered holders. Supply-chain and insurance second-order effects matter: accelerating monthly launches compress supplier lead times (payloads, phased-array antennas) and elevate per-launch insurance premiums, which can materially widen per-satellite lifetime costs versus base case models.

Regulatory and commercial distribution risks remain underrated — global roaming agreements, carrier wholesale economics, and handset OEM certification all take quarters to negotiate; missing small but critical milestones (e.g., a carrier trial or handset pass) can push commercial monetization timelines by 6–18 months. Valuation is effectively a binary play priced for success; a calibrated exposure that monetizes asymmetric upside while capping downside through time-limited option structures is the more efficient approach than a naked long equity slot.

Key Decisions for Investors

• Bullish, defined-risk: Buy ASTS Jan-2028 100/220 call spread (debit). Rationale: captures multi-quarter commercial activation upside while capping premium; target >=2.5x payoff if constellation milestones and initial ARPU proofs occur. Size 2–4% notional of satellite/space allocation; exit half at 1.5x, full at 2.5x or on missed milestone after next 4 launches.
• Hedge/contrarian pair: Short ASTS via 3–6 month put spread (buy 1x lower strike put, sell 2x further OTM put) while buying NVDA 6–9 month near-the-money calls. Rationale: protects downside from execution or launch failure and keeps upside exposure to secular AI tailwinds. Target asymmetric P/L where max loss on ASTS leg is limited to premium; net trade benefits from a safety-first re-pricing of high-beta names.
• Event-focused short-vol: Sell a tight covered call against existing ASTS shares or buy-to-open a collar (long shares, sell 3–6 month call, buy 3–6 month put) into each scheduled launch window. Rationale: monetizes elevated implied vols ahead of launches and limits single-event drawdowns. Roll or unwind within 2 weeks post-launch depending on outcome.
• Liquidity/flow alert (monitor-only): Track large-manager rebalancing dates and 13F windows — if institutional buying momentum slows, be prepared to trim exposure quickly as liquidity dries and delta-hedged desks buyback shares, amplifying downside within 5–10 trading days.